Vested Success: Aspen’s Leadership Benefits from Lucrative Bonus Shares

  • Aspen Pharmacare's directors and officers received deferred bonus shares under an incentive scheme, with substantial values awarded.
  • The vesting of these shares reflects the company's commitment to retaining and motivating top talent while aligning their interests.
  • The announcement, made in compliance with JSE Listings Requirements, highlights the company's dedication to long-term growth and value creation.

Aspen Pharmacare Holdings Limited (Share Code: APN) has announced the vesting of deferred bonus shares awarded in 2020 to key members of its leadership team. The vesting of these shares is part of the Aspen South African Management Deferred Incentive Scheme. The announcement, in compliance with the Listings Requirements of the JSE Limited, reveals the details of the transaction, including the directors, company secretary, and prescribed officers of the company who have received these shares.

Directors and Officers Benefit from Deferred Bonus Shares

The deferred bonus shares, which have now vested, were delivered off-market on October 20, 2023, at a price of R 164.01 per share. The total value of the shares to be delivered to the recipients is substantial, underscoring the significance of the incentive scheme and the company’s commitment to rewarding its key personnel.

Here is a summary of the details for each recipient:

RecipientPositionNumber of SharesPrice per Share (R)Total Value (R)
Stephen Bradley SaadDirector35,862164.015,881,726.62
Sean Matthew CapazorioDirector17,507164.012,871,323.07
Michael Guy AttridgePrescribed Officer29,647164.014,862,404.47
Reginald HamanPrescribed Officer & Company Secretary15,442164.012,532,642.42
Lorraine Angela HillPrescribed Officer25,141164.014,123,375.41
Zizipho MmangoPrescribed Officer2,681164.01439,710.81

The Aspen South African Management Deferred Incentive Scheme

The Aspen South African Management Deferred Incentive Scheme is designed to incentivize and reward key members of Aspen Pharmacare’s leadership team, aligning their interests with the long-term success and performance of the company. The scheme includes the vesting of deferred bonus shares, as seen in this recent announcement.

The company has stated that no dealing was involved in the clearance for these transactions, indicating that the shares were delivered as part of the incentive scheme rather than as a result of any market activity.

A Sign of Confidence and Commitment

The vesting of deferred bonus shares to directors, the company secretary, and prescribed officers is a common practice among publicly-traded companies and serves as a means to retain and motivate top talent. It also demonstrates the company’s confidence in its leadership team and its commitment to long-term shareholder value.

Aspen Pharmacare, a South African-based multinational pharmaceutical company, has been a significant player in the global pharmaceutical industry. With a presence in over 150 countries and a diverse portfolio of products, the company’s performance has a direct impact on South Africa’s economy

Quick Poll

Related

Rateweb

South Africa’s primary source of financial tools and information

Contact Us

admin@rateweb.co.za

Disclaimer

Rateweb strives to keep its information accurate and up to date. This information may be different than what you see when you visit a financial institution, service provider or specific product’s site. All financial products, shopping products and services are presented without warranty. When evaluating offers, please review the financial institution’s Terms and Conditions.

Rateweb is not a financial service provider and should in no way be seen as one. In compiling the articles for our website due caution was exercised in an attempt to gather information from reliable and accurate sources. The articles are of a general nature and do not purport to offer specialised and or personalised financial or investment advice. Neither the author, nor the publisher, will accept any responsibility for losses, omissions, errors, fortunes or misfortunes that may be suffered by any person that acts or refrains from acting as a result of these articles.